Raras
Buscar doenças, sintomas, genes...
Tétano
ORPHA:3299CID-10 · A33CID-11 · 1C13DOENÇA RARA

Doença infecciosa grave que se segue à contaminação de feridas pela bactéria Gram-positiva Clostridium tetani. A bactéria produz uma neurotoxina chamada tetanospasmina, que causa espasmos musculares na mandíbula e em outros locais anatômicos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença infecciosa grave que se segue à contaminação de feridas pela bactéria Gram-positiva Clostridium tetani. A bactéria produz uma neurotoxina chamada tetanospasmina, que causa espasmos musculares na mandíbula e em outros locais anatômicos.

Pesquisas ativas
23 ensaios
401 total registrados no ClinicalTrials.gov
Publicações científicas
27.518 artigos
Último publicado: 2026 Apr 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: A33
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
3 sintomas
🫃
Digestivo
3 sintomas
🧠
Neurológico
3 sintomas
💪
Músculos
2 sintomas
❤️
Coração
2 sintomas
🧬
Pele e cabelo
1 sintomas

+ 14 sintomas em outras categorias

Características mais comuns

90%prev.
Rigidez muscular
Muito frequente (99-80%)
90%prev.
Risus sardonicus
Muito frequente (99-80%)
90%prev.
Disfagia
Muito frequente (99-80%)
90%prev.
Opistótono
Muito frequente (99-80%)
90%prev.
Trismo
Muito frequente (99-80%)
55%prev.
Lesão cutânea localizada
Frequente (79-30%)
30sintomas
Muito frequente (5)
Frequente (8)
Ocasional (17)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 30 características clínicas mais associadas, ordenadas por frequência.

Rigidez muscularMuscle stiffness
Muito frequente (99-80%)90%
Risus sardonicus
Muito frequente (99-80%)90%
DisfagiaDysphagia
Muito frequente (99-80%)90%
OpistótonoOpisthotonus
Muito frequente (99-80%)90%
TrismoTrismus
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico27.518PubMed
Últimos 10 anos200publicações
Pico2026139 papers
Linha do tempo
2026Hoje · 2026🧪 1980Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 37
2Fase 23
1Fase 14
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tétano

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

10 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

401 ensaios clínicos encontrados, 23 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
5.510 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 5.510

#1

Caregiver and healthcare professional perspectives on drivers of routine immunisation uptake in East New Britain, Papua New Guinea: a qualitative study.

BMJ public health2026

Immunisation coverage varies across Papua New Guinea (PNG), with 40% of children in East New Britain Province (ENBP) classified as zero-dose (children missing diphtheria-tetanus-pertussis vaccine first dose (DTP1)) and 55% as under-immunised (missing DTP3) in 2023. This study aimed to understand routine childhood immunisation enablers and barriers in areas of ENBP reported to have highly variable DTP1, DTP3 and measles-rubella first-dose (MR1) coverage. Qualitative in-depth semi-structured interviews were conducted face-to-face with caregivers of children aged 9-23 months and healthcare professionals in Gazelle and Kokopo districts. Local research officers conducted interviews in Tok Pisin and English. Data were thematically analysed and mapped across the six UNICEF Journey to Health and Immunisation framework stages. 33 caregivers and 28 healthcare professionals were interviewed. Despite finding that a high proportion of caregivers' children had received DTP, DTP3 and MR1, participants identified a myriad of contextual caregiver and healthcare professional enablers and barriers to routine immunisation. Caregiver enablers included support provided by families and community-based services; barriers included limited immunisation knowledge, financial and travel challenges, and limited availability of healthcare professionals. Healthcare professional enablers included increased operational funds and working with community leaders, while barriers were focused on service delivery including costs, non-functioning aid posts and vaccine stockouts. Strategies suggested by participants for improving vaccine uptake included developing tailored immunisation communication materials, engaging community members to support routine immunisation promotion activities, and strengthening coordination between communities and healthcare professionals. This study highlights the challenge of identifying and including zero-dose children and their caregivers in research but still provides useful contextual focus points to enhance and inform tailored strategies to strengthen immunisation service delivery. These include strategies that improve bidirectional coordination and communication between healthcare professionals, community and religious leaders about routine immunisation, increase immunisation knowledge and strengthen community-based services for vaccine delivery.

#2

Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024.

BMJ public health2026

To describe the themes identified in the epidemiology of diphtheria and pertussis outbreaks in the Americas (2013-2024), with a particular focus on vaccination coverage, trends and control strategies. Scoping review. Systematic searches were conducted in PubMed and Embase (2024), supplemented by a search of Latin American and Caribbean Health Sciences Literature (LILACS) in December 2025. Regional case data and vaccination coverage were sourced from the Pan American Health Organization (PAHO)/WHO and UNICEF electronic joint reporting form (eJRF). The study reviewed literature and health reports focusing on diphtheria and pertussis outbreaks and vaccination coverage. Thematic analysis identified themes in the literature on the epidemiology and control strategies of diphtheria and pertussis as well as outbreak reporting and mortality. The retrospective regional data analysis encompassed aggregated eJRF data (2013-2024) on cases and on diphtheria-pertussis-containing vaccination coverage. Of 82 articles identified across 14 countries, 28 met the inclusion criteria. Diphtheria cases peaked in 2017-2018 and have been on an upward trend since. Pertussis cases surged to 66 184 in 2024, with 10 countries reporting high numbers and 17 having their third dose of the vaccine against diphtheria, tetanus and pertussis (DTP3) coverage below 90%. Outbreaks are often linked to low DTP3, inconsistent vaccination coverage, gaps in maternal and booster doses, inadequate surveillance and socioeconomic disparities. However, two countries with high DTP3 coverage (eg, the USA, Canada) still experienced pertussis outbreaks, showing the disease's complexity. Experts recommend scaling up vaccination and strengthening surveillance to address these challenges. Diphtheria and pertussis are resurging in the Americas. The growing number of 'zero-dose' children and socioeconomic disparities in vulnerable communities are exacerbating the problem. A comprehensive approach is recommended, prioritising increased vaccination efforts, strengthened surveillance and ensuring equitable access to healthcare services.

#3

Global patterns and disparities in maternal and child health: a panel analysis of global health observatory and world development indicators data, 2000-2023.

BMJ open2026 Mar 23

This study aims to evaluate global trends in maternal and child health-related indicators in the Millennium Development Goals (MDG) and Sustainable Development Goal (SDG) eras, examine whether these associations differ across regions and income groups and assess their impact on life expectancy (LE) at birth. We conducted a country-level panel analysis using data from 2000 to 2023 obtained from the Global Health Observatory and the World Development Indicator database. All WHO Member States with available data were included. Data on under-five mortality rate (U5MR), maternal mortality ratio (MMR), neonatal mortality rate (NMR), skilled birth attendance, ratio of nurses and midwives, total fertility rate (TFR), LE, prevalence of anaemia and hypertension in women aged 15-49 years, diphtheria tetanus toxoid and pertussis (DTP3) vaccine coverage, gross domestic product and government health expenditure as a percentage of GDP were collected, cleaned and prepared for analysis. Missing values (<10%) were imputed using linear interpolation and 5-year mean methods. Descriptive statistics and panel regression analyses were conducted to examine associations between maternal and child health indicators and LE. In addition, Joinpoint regression models were applied to assess temporal trends and estimate annual percent changes (APCs) during the MDG and SDG eras. All statistical analyses were performed using Stata MP version 17.0. Sensitivity analyses were conducted to evaluate the robustness of the findings. Trends in LE and maternal and child health indicators and maternal and child-related factors associated with LE. Maternal and child health improved substantially, with faster progress during the MDG era (2000-2015) compared with the SDG era (2015-2023). The MMR declined by 130.30 (100 in MDG vs 30.30 in SDG) deaths per 100 000 live births overall, from 327.60 (95% UI: 308.80-348.60) in 2000 to 197.30 (95% UI: 174.50-234.00) in 2023. Similarly, U5MR declined by 39.95 (28 in the MDG vs 11.95 in the SDG era) deaths, from 76.67 (95% UI: 75.70-77.86) to 36.72 (95% UI: 34.66-41.09) deaths per 1000 live births. The NMR decreased by 13.38 per 1000 live births, from 30.71 (95% UI: 29.91-31.58) to 17.33 (95% UI: 16.25-19.41) deaths, and LE increased by 6.6 years, from 66.77 (95% UI: 66.23-67.18) to 73.33 (95% UI: 72.73-73.93) globally. Fixed-effects regression results showed that higher U5MR (β=-0.0697, 95% CI -0.080 to -0.060, p<0.001), MMR (β=-0.0118, 95% CI -0.020 to -0.010, p<0.001), TFR (β=-0.0258, 95% CI -0.040 to -0.020, p<0.001) and prevalence of anaemia (β=-0.0223, 95% CI -0.030 to -0.010, p<0.001) were associated with reduced LE, whereas skilled birth attendance (β=0.0417, 95% CI 0.030 to 0.050, p<0.001), DPT3 coverage (β=0.0425, 95% CI 0.030 to 0.050, p<0.001) and GDP (β=0.0041, 95% CI 0.001 to 0.010, p=0.01) were associated with increased LE. Despite progress in maternal and child health, gaps remain, particularly in low-income and lower-middle-income countries. Strengthening and retaining the health workforce, expanding access to immunisation and family planning services and improving early detection and management of hypertension and anaemia among women are critical to sustaining gains and accelerating improvements in LE.

#4

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance.

BMJ paediatrics open2026 Mar 23

Periodic vaccine safety checks are a crucial component of any country's pharmacovigilance system. Unwanted reactions following childhood vaccination are unacceptable to the public, making rapid safety checks and alerts essential for maintaining public confidence. The study evaluates the safety of childhood vaccines in the paediatric population through active surveillance and explores various predictors for the development of adverse event following immunisation (AEFI) based on population characteristics. A cohort event monitoring study was designed to identify AEFIs in children receiving at least one childhood vaccine under the Universal Immunisation Programme (UIP) at the study site. Both active surveillance (via telephone follow-up calls) and passive surveillance (from healthcare workers) were included. Potential predictors of AEFIs were evaluated using the χ2 test, and relative risk was calculated. The study estimated an AEFI incidence rate of 10.37%, with 3.47% (1.27 events/1000 doses) being serious reactions requiring hospitalisation. The highest incidence was with the Pentavac vaccine (diphtheria, tetanus, pertussis, hepatitis B, Hib) at 19.21% (218 events/1000 doses), while the lowest incidence was observed with the oral polio vaccine at 0.13% (1.32 events/1000 doses). Most reported Adevrse Events were solicited (34.83 events/1000 doses), while unsolicited events accounted for 1.69/1000 doses. The most common reaction was fever (23.75 events/1000 doses), followed by pain at injection site (4.98 events/1000 doses). One death following Pentavac vaccination was reported but later deemed coincidental. Overall, 90.62% of the reactions were vaccine product-related, 4.76% coincidental, 2.70% immunisation error-related and 0.39% were indeterminate. Predictors of AEFIs included paediatric population, delayed immunisation, nutritional deficiencies and comorbid status of the child and children from affluent families. Childhood vaccines included in the UIP have shown a favourable safety profile. Serious reactions are infrequent, emphasising the need for thorough investigation and clear communication to differentiate them from coincidental reactions, which can occur more frequently in this age group.

#5

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

The Lancet. Infectious diseases2026 Mar 19

Few data are available comparing the WHO diphtheria-tetanus-pertussis (DTP)-containing vaccine schedule with reduced-dose or delayed three-dose schedules in infants. We aimed to identify an alternative schedule that is non-inferior or superior to the WHO schedule in maintaining early pertussis antibody levels before booster, while creating space for integration of new vaccines. In two parallel, open-label, randomised, non-inferiority trials in Uganda and Nepal, healthy infants aged 42-50 days were randomised in a 4:4:4:3:3 ratio via an online system to five diphtheria-tetanus-whole-cell pertussis-Haemophilus influenzae type b-hepatitis B (DTwP-Hib-HepB) vaccination schedules (WHO schedule [ages 6, 10, and 14 weeks]; reduced two-dose schedules at ages 6 and 14 weeks or ages 2 and 4 months; or delayed three-dose schedules at ages 2, 3, and 4 months or ages 2, 4, and 6 months), using site-stratified block randomisation with a block size of 18. The primary outcome was the pre-booster IgG antibody response against pertussis antigens (pertussis toxin; filamentous haemagglutinin [FHA]; pertactin; fimbriae 2 and 3 [Fim 2 and 3]). Antibody responses during and 1 month after the primary series were assessed as secondary endpoints. The two-dose schedules were compared with the WHO schedule as primary analyses, and the exploratory analyses were to compare delayed three-dose schedules with the WHO schedule. All these analyses were conducted in the per-protocol population. For the primary endpoint, non-inferiority margins for geometric mean ratios (GMRs) between two-dose and WHO schedules were calculated for each pertussis antigen separately as 35% of the standard deviation of the geometric mean concentrations of the WHO group, and non-inferiority was concluded if the lower bound of the 95% CI of the GMR exceeded the non-inferiority margin. A non-inferiority margin of 0·67 was used for all other non-inferiority comparisons. The trials were registered with ISRCTN (Uganda [ISRCTN60356654] and Nepal [ISRCTN12240140]) and are complete. Between Oct 1, 2021, and July 12, 2022 (Uganda) and Dec 5, 2021, and Feb 26, 2023 (Nepal), 956 infants were recruited per country and randomly allocated across the five study groups; pre-booster analyses were conducted in 876 participants in Uganda and 851 participants in Nepal. Two-dose schedules at ages 6 and 14 weeks and ages 2 and 4 months did not meet non-inferiority criteria for pertussis antibodies pre-booster, except FHA (non-inferiority margin 0·59) in Nepal (6 and 14 weeks GMR 0·83 [95% CI 0·61-1·13]; 2 and 4 months 1·20 [0·88-1·64]). Delayed three-dose schedules at ages 2, 3, and 4 months and ages 2, 4, and 6 months produced similar or higher post-primary series and pre-booster responses compared with the WHO schedule, but the WHO schedule achieved higher antibody responses against all pertussis antigens, except FHA in Nepal, at age 3 months. The WHO DTP schedule is the preferred schedule in high-pertussis-burden settings, as it elicits the greatest antibody responses in the first 3 months of life when infants are particularly vulnerable. Although delayed three-dose schedules may be considered in low-risk contexts and in settings with maternal immunisation programmes, early infant protection should guide policy decisions. Gates Foundation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC13.441 artigos no totalmostrando 197

2026

Caregiver and healthcare professional perspectives on drivers of routine immunisation uptake in East New Britain, Papua New Guinea: a qualitative study.

BMJ public health
2026

Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024.

BMJ public health
2026

Global patterns and disparities in maternal and child health: a panel analysis of global health observatory and world development indicators data, 2000-2023.

BMJ open
2026

Addressing the crises of declining vaccination rates and measles resurgence by promoting health literacy.

JAAPA : official journal of the American Academy of Physician Assistants
2026

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance.

BMJ paediatrics open
2026

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

The Lancet. Infectious diseases
2026

Global burden shift from infectious to non-communicable neurological disorders in adolescents and young adults (10-24 years): findings from the global burden of disease study 1990-2021.

International journal of clinical pharmacy
2026

Prevalence, spatial patterns and determinants of zero-dose vaccination among children aged 12-23 months in Sub-Saharan Africa: A multilevel spatial analysis.

PloS one
2026

Intrauterine Aluminium Exposure Due to Dietary Content Alters Social Behaviours in Wistar Rat Offsprings.

Annals of neurosciences
2026

10 years trends and hospitalization outcomes of non-neonatal tetanus: a large-scale multicenter retrospective study in China.

Critical care (London, England)
2026

Seroprevalence of diphtheria, tetanus, pertussis among healthcare workers (HCWs) - A cross-sectional study at the National Centre for Infectious Diseases and Tan Tock Seng Hospital, Singapore.

Human vaccines &amp; immunotherapeutics
2026

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine.

Human vaccines &amp; immunotherapeutics
2026

Associations of mid-childhood per- and polyfluoroalkyl substances and early childhood metals with mid-childhood antibody titers.

Environmental epidemiology (Philadelphia, Pa.)
2026

Severe rhabdomyolysis and refractory dysautonomia complicating generalized tetanus in an unvaccinated child: A case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Residential differentials in prevalence and factors associated with tetanus toxoid uptake among women of reproductive age in Nigeria: a Multiple Indicator Cluster Survey analysis (MICS 2021).

BMC public health
2026

Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations.

Allergy and asthma proceedings
2026

Costs of managing adverse reactions to hexavalent vaccines: Comparison of DT3aP-HBV-IPV/Hib and DT2aP-HBV-IPV-Hib in France and Spain.

Human vaccines &amp; immunotherapeutics
2026

Adherence to Recommended Immunisation Schedules for Patients With Inflammatory Bowel Disease (IBD) on Biologics: A Retrospective Study at Our Lady's Hospital, Navan, Ireland.

Cureus
2026

Recommended Vaccines for Immunocompetent Older Adults: Work Group Report of the AAAAI Allergy and Asthma in Older Adults Committee.

The journal of allergy and clinical immunology. In practice
2026

Perturbation-induced responses improved seizure forecasting in epileptic rats.

Epilepsia
2026

Effectiveness of the influenza and Tdap vaccination educational module (InTroDuce-Programme) on knowledge and intention for antenatal vaccination: A cluster randomised controlled trial protocol among pregnant women in Malaysian primary care clinics.

PloS one
2026

Pregnancy exposure to individual phthalate concentrations and their mixtures in relation to pediatric serum antibody response.

European journal of epidemiology
2026

Evaluation of vaccine immunity against tetanus, hepatitis B, measles, mumps, rubella and varicella, in migrant adolescents aged 13 to 18 years arriving in Geneva in 2023.

European journal of pediatrics
2026

A study on knowledge, attitude and practices (KAP) towards adult immunizations among health care professionals.

Journal of family medicine and primary care
2026

Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial.

Transplantation direct
2026

Clinical observations of tetanus toxin plus decoy, Snoretox-1, a novel targeted neuromuscular stimulant, in a pilot study of 6 British bulldogs with BOAS.

Veterinary journal (London, England : 1997)
2026

Horse immune response of recombinant Lawsonia intracellularis vaccine: Assessing the immunomodulatory impact of probiotic supplementation.

Research in veterinary science
2026

Meningococcal quadrivalent ACYW-TT conjugated vaccine at 6-23 months: phase III study (US/Puerto Rico).

Pediatric research
2026

A flexible antenna immunosensor with AuPt-graphene film for wireless detection of tetanus toxin.

Analytica chimica acta
2026

Associations of serum PFAS with COVID-19 antibody levels among fully vaccinated adults.

Environmental research
2026

Uncommon intraoral source of generalized tetanus: Case report and review of intensive care strategies.

IDCases
2025

Open Clavicle Fracture: A Case Report.

JNMA; journal of the Nepal Medical Association
2026

Mortality and Associated Factors Among Adult Tetanus Patients Admitted at Public Hospitals in Bahir Dar City, Ethiopia: A Cross-Sectional Study.

Health science reports
2025

Cricothyroidotomy for Can't Intubate, Can't Oxygenate Situation in Emergency Department.

JNMA; journal of the Nepal Medical Association
2026

Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.

Gastroenterologia y hepatologia
2026

Botulinum neurotoxins: A distinct subclass of SNARE-Cleaving endopeptidases.

Anaerobe
2026

When Neurology Meets Art History: Tetanus (or Rabies) in a 19th-Century Painting (Neurology and Art).

European neurology
2026

An Atypical Presentation of Guillain-Barré Syndrome: Bilateral Facial Nerve Palsy With Preserved Reflexes.

Cureus
2026

Factors associated with pertussis infection and suspected cases in the Aseer Region, Saudi Arabia: a retrospective cross-sectional analysis study.

Frontiers in public health
2026

Generalized Tetanus in an Unvaccinated Adolescent: A Case Report on Successful Management in a Resource-Limited Setting.

International medical case reports journal
2026

Geographic disparities and determinants of DTP3 vaccination coverage among children aged 0-59 months in Somalia: a multilevel analysis.

Conflict and health
2026

B lymphocytes that enter the germinal center late preferentially differentiate into memory cells that recognize subdominant epitopes.

Immunity
2026

Antenatal Care and Perinatal Mortality in Low- and Middle-Income Countries: Insights for Maternal and Newborn Health System.

Mayo Clinic proceedings. Innovations, quality &amp; outcomes
2026

Tetanus Control in the United States and Global Disaster Settings: Public Health Disparities and Prevention Strategies.

Medicina (Kaunas, Lithuania)
2026

Bayesian spatiotemporal modelling of neonatal, infant and under-5 mortality (2000-2022) in 41 Asian countries: a population-level observational study.

BMJ open
2026

Evaluation of the MenACWY Vaccination Catch-Up Campaign Among Adolescents in Madrid: Coverage, Trends, and Determinants.

Vaccines
2026

Timeliness of Routine Vaccination, Catch-Up Completion, and Immune Function in Chinese Children with Special Healthcare Needs: A Retrospective Cohort Study.

Vaccines
2026

Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria-tetanus-acellular pertussis (DTaP) vaccinations.

Human vaccines &amp; immunotherapeutics
2026

Seroepidemiological study of pertussis in Henan Province, China, and prediction of the effectiveness of a new immunization strategy.

Biosafety and health
2026

Impact of CD19 CAR T-Cell Therapy on Pathogen-Specific Antibody Titers in Lymphoma Patients.

Transplant infectious disease : an official journal of the Transplantation Society
2026

Annual Immunisation Coverage Report 2023.

Communicable diseases intelligence (2018)
2026

Prefrontal-medullary circuitry is necessary for sex-specific responses to metabolic stress in rats.

bioRxiv : the preprint server for biology
2026

Global burden, trends, and projections of tetanus for 2050: Based on the 2021 Global Burden of Disease Study.

Chinese journal of traumatology = Zhonghua chuang shang za zhi
2026

Trends and recovery of routine childhood immunization before, during, and after the COVID-19 pandemic in Ethiopia: A five-year trend analysis.

Vaccine
2026

Gold/vertical-graphene-based dual-channel electrochemical immunosensor for point-of-care testing of tetanus toxin in blood.

Biosensors &amp; bioelectronics
2026

A Potential Case of Tetanus-Diphtheria Vaccine-Induced Immune Thrombocytopenia.

Cureus
2026

Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system.

Frontiers in cellular and infection microbiology
2026

Tetanus infection in an 11-year-old male with full infant vaccination history: a rare case report.

BMC pediatrics
2026

Association of parental vaccination readiness and descriptive norms with childhood vaccination status.

Vaccine
2026

An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy in England.

Vaccine
2026

Economic evaluation of national immunization program vaccines in China: a systematic review.

Health economics review
2026

Generation of a SV2A knockout human embryonic stem cell line by CRISPR/Cas9 system.

Stem cell research
2025

Risk signal assessment of Tdap vaccine use alone by pregnant women: An updated pharmacoepidemiological study.

Frontiers in cellular and infection microbiology
2026

[Clinical characteristics and outcomes of pertussis encephalopathy in 17 children].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2026

Timeliness of vaccine administration among children in urban informal settlements in Nairobi, Kenya.

PLOS global public health
2026

The Clean Pass: Upper Limb Impalement with Complete Neurovascular Preservation.

Journal of orthopaedic case reports
2026

Intrathecal Human Tetanus Immunoglobulin for Post-Neonatal Tetanus in Resource-Limited Settings: An Old Idea with New Evidence.

The American journal of tropical medicine and hygiene
2026

Effectiveness of Intrathecal Tetanus Immunoglobulin in Postneonatal Tetanus: A Retrospective Comparative Study (TIG-TET Study).

The American journal of tropical medicine and hygiene
2026

Pertussis Outbreak Investigation in a Korean Middle School: Insights on Tdap and Td Vaccination.

Journal of Korean medical science
2026

Knowledge, attitudes and practices towards immunization among adult population in a tertiary care hospital-exploratory survey.

Clinical and experimental vaccine research
2025

Ten-year analysis of the epidemiologic characteristics of whooping cough in Kyrgyzstan.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
2026

Factors associated with tetanus, diphtheria and pertussis (Tdap) vaccination acceptance among pregnant women: a cross-sectional study.

BMC infectious diseases
2026

Disparities and barriers to life-course vaccination in Ethiopia: Evidence from a household survey.

Human vaccines &amp; immunotherapeutics
2026

Opisthotonus: Revisiting a classic movement disorder.

Journal of the neurological sciences
2026

Modeling Zero-Dose Children in Ethiopia: A Machine Learning Perspective on Model Performance and Predictor Variables.

JMIR pediatrics and parenting
2026

Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib).

Vaccine
2026

Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China.

Emerging microbes &amp; infections
2026

A Glycopeptide Mosaic Vaccine Elicits Robust Antitumor Immunity by Targeting Glycan Heterogeneity.

JACS Au
2026

Penetrating Foot Injury Caused by a Retained Wood Screw: A Case Report.

Cureus
2025

Insights into vaccination: a cross-sectional study of knowledge, attitudes, and barriers among community pharmacists in Türkiye.

Frontiers in public health
2026

Enhancing Adolescent Vaccine Acceptance: A Multi-Component Intervention Study on 13-Year-Old Tetanus-Diphtheria Vaccination.

Public health nursing (Boston, Mass.)
2026

Portal vein thrombosis as a clinical dilemma in Echis carinatus envenomation: a case report and review of the literature.

Thrombosis journal
2026

Co-administration of recombinant zoster vaccine with other recommended vaccines among older adults in the United States of America.

Preventive medicine
2026

Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study.

Infectious diseases and therapy
2026

Liver Safety Assessment of an Indonesian Hexavalent Vaccine Candidate Through Histopathology and ALT/AST Evaluation in Rats and Rabbits.

Vaccines
2026

Alternative Childhood Vaccination Schedules in Israel: A Mixed-Methods Study on Prevalence, Patterns, and Public Health Implications.

Vaccines
2025

Trends in Women's Empowerment and Their Association with Childhood Vaccination in Cambodia: Evidence from Demographic and Health Surveys (2010-2022).

Vaccines
2025

Preclinical Study on Sabin Strain-Based DTaP-sIPV/Hib Pentavalent Vaccine: Evaluation of Repeated-Dose Toxicity and Immunogenicity.

Vaccines
2026

Complete Neutralization of Tetanus Neurotoxin by Alpaca-Derived Trivalent Nanobodies Aimed at Veterinary Medical Applications.

Veterinary sciences
2025

Severe Generalized Tetanus in a Chimpanzee (Pan troglodytes) Under Human Care: A Case Report from the Republic of Congo.

Veterinary sciences
2026

The effect of pertussis vaccination during pregnancy on the binding epitopes and avidity of anti-pertussis toxin IgG antibodies in infants and their mothers.

The Journal of infectious diseases
2026

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

NEJM evidence
2025

Finding the Gaps: Integrated Serosurveillance and Spatial Clustering of Vaccine Preventable Diseases in Samoa, 2018-2019.

Tropical medicine and infectious disease
2026

Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells.

Toxins
2026

Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial.

The Lancet. Infectious diseases
2025

Descriptive epidemiology of animal-induced injuries in Sandun Town, Hangzhou, China.

Frontiers in public health
2026

Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib.

Dermatology and therapy
2026

The Prevalence and Impact of Vaccination Programs: Differences Between Nursing Homes and Assisted Living Communities.

Journal of the American Medical Directors Association
2026

The role of the media in the coverage of childhood vaccination in children under two years of age in Peru, ENDES 2021-2024.

PLOS global public health
2026

From School-Based Immunization to Family Health Centers: the Impact of a 2020 Policy Change on 13-Year-Old Tetanus-Diphtheria Vaccine Coverage in Turkey.

Health care analysis : HCA : journal of health philosophy and policy
2026

Coral Fragment Injury Simulating a Sea Urchin Sting: A Rare Case Report from Mauritius in a Tourist.

Annals of African medicine
2025

[Hidden danger: a tare cause of painful muscle spasms after long-lie].

Praxis
2026

Vaccine delay in routine childhood vaccines in the post-COVID-19 era in Jiangning, Nanjing, China.

Preventive medicine reports
2026

Pyramidal neurons proportionately alter cortical interneuron subtypes.

Nature
2026

Impact of a community-led intervention on the uptake of childhood vaccines in Liverpool: a protocol for a synthetic control evaluation.

BMJ open
2026

Emergency response and clinical treatment analysis of a mass wasp sting incident involving 38 tourists: A case report.

Medicine
2025

The impact of social vulnerability on primary vaccine coverage in children with sickle cell disease.

Frontiers in public health
2026

Assessment of health technician students' awareness of dental trauma in Turkey.

BMC medical education
2026

Safety, immunogenicity, and lot consistency of a 13-valent pneumococcal conjugate vaccine in Chinese children aged 2-5 years: A phase III study.

Vaccine
2026

Chemoenzymatic Synthesis of Glycopeptide Library Decodes Sialylation-Dependent Immunodominance to Enable a Potent Multicomponent Antitumor Vaccine.

Angewandte Chemie (International ed. in English)
2026

A rare case of non-wound tetanus mimicking botulism successfully managed in the ICU.

IDCases
2025

Low maternal pertussis protection and quantified infant risk: supporting maternal Tdap vaccination in China.

Frontiers in immunology
2026

Vaccine acceptance in gravid patients in the COVID-19 era.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2026

Improved pertussis vaccine uptake following in-hospital administration among pregnant women living with HIV.

Archives of gynecology and obstetrics
2026

Tetanus in a developing nation: a rare disease in the vaccination era?

BMJ case reports
2026

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021).

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Immunological responses to tetanus, diphtheria, pertussis (Tdap) vaccine in Brazilian hematopoietic stem cell transplant recipients.

Vaccine
2026

Use of Bradford Hill causality criteria in cluster of events attributable to pentavalent vaccine: cohort and case-non-case studies, Brazil, 2020-2022.

Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil
2026

RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2026

Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trial.

The Lancet. Microbe
2026

Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer.

Gene therapy
2026

Tetanus Toxoid Vaccine Uptake and Associated Factors Among Reproductive Age Women in Mogadishu, Somalia: A Cross-Sectional Study.

IJID regions
2026

Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis.

JAMA network open
2026

SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults.

European journal of immunology
2026

The many journeys of botulinum neurotoxins and the bacteria that produce them-evolutionary, geographic, and research-related movements that have contributed to our understanding of a diverse pathogen.

Microbiology and molecular biology reviews : MMBR
2026

Exploration of factors influencing the insufficient rate of tetanus vaccination among young women in an urban health zone: A cross-sectional study.

Medicine
2026

Social capital and uptake of primary healthcare during protracted displacement: Evidence from four refugee settlements in northern Uganda.

Social science &amp; medicine (1982)
2026

[Vaccination of Older Adults in Portugal: Recommendations from the Geriatrics Study Group of the Portuguese Society of Internal Medicine].

Acta medica portuguesa
2025

Safety and immunogenicity of a 3-dose schedule of a quadrivalent meningococcal tetanus toxoid conjugate vaccine administered concomitantly with routine pediatric vaccines to infants and toddlers: A descriptive randomized study.

Human vaccines &amp; immunotherapeutics
2025

Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up.

Frontiers in immunology
2025

Vaccinations for Expecting Mothers to Improve Pregnancy Care in Middle Tennessee.

Pathogens (Basel, Switzerland)
2025

Prevalence and risk factors of stillbirths among pregnant women from twelve high-volume birthing facilities of Karachi, Pakistan: a longitudinal cohort study.

BMC pregnancy and childbirth
2025

Seroprevalence of diphtheria and tetanus antibodies among children and adolescents in high- and low-immunization coverage areas in the Lao People's Democratic Republic.

PloS one
2026

Assessing vaccination coverage and antibody levels for measles, pertussis, and tetanus in Boende, DR Congo: Implications for maternal and child health.

Vaccine
2025

[Risk factors associated with maternal and child pertussis vaccination coverage in MexicoFatores de risco associados à vacinação materno-infantil contra a pertússis no México].

Revista panamericana de salud publica = Pan American journal of public health
2025

The use of recommended vaccinations among patients with chronic diseases in relation to attitudes toward vaccination and anxiety levels.

BMC infectious diseases
2025

[Expert consensus on the application of passive immune preparation for post-exposure prophylaxis against tetanus].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
2026

Large differences in MMR and DTaP-IPV vaccination coverage among primary schools by denomination, the Netherlands, 2024.

Vaccine
2025

Pregnant Women and Vaccine Safety in Uganda: Knowledge, Barriers, and Opportunities for Engagement.

Vaccines
2025

Systematic review of mHealth and digital health interventions to improve childhood vaccination uptake in 19 Sub-Saharan African countries.

PloS one
2026

Ensuring structural integrity of Hib capsular polysaccharide in conjugate vaccine manufacturing by 1H NMR and HPSEC-MALLS/RI.

Vaccine
2025

A 15-year population-based study on incidence and vaccination coverage in pediatric inflammatory bowel disease in Italy.

Pediatric investigation
2026

Impact of pregnancy on longitudinal pertussis antibody responses to Tdap vaccine in Guatemala.

Vaccine
2025

Clinically diagnosed tetanus in a 58-year-old female with breast fungating mass.

Tropical medicine and health
2026

A DC-Sensitive Video/Electrophysiology Monitoring Unit for Long-Term Continuous Study of Seizures and Seizure-Associated Spreading Depolarization in a Rat Model.

eNeuro
2025

Evaluation of anti-tetanus IgG antibody levels and influencing factors in patients undergoing hemodialysis.

Frontiers in immunology
2025

Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
2025

Comparison of characteristics and injury patterns between minor and adult patients seeking emergency cosmetic suture for facial lacerations: data from a tertiary plastic surgery hospital in Beijing, China.

Frontiers in public health
2026

Monitoring the SDG immunization indicator: Approaches and challenges.

Vaccine
2025

[Modern approach in management of patients with lower third face lacerated wounds].

Stomatologiia
2025

Expert consensus on vaccination as a primary prevention strategy for women of reproductive age, pregnant, or adulthood.

Revista colombiana de obstetricia y ginecologia
2025

Time Required for the Restitution of Extra Initial Force in Fast Motor Units of the Rat Medial Gastrocnemius Muscle.

Medicine and science in sports and exercise
2025

Tetanus toxoid immunization coverage and its determinants among pregnant women in Somalia: A cross-sectional analysis of the 2020 Demographic and Health Survey.

Human vaccines &amp; immunotherapeutics
2025

Association of age-appropriate vaccination status at 24 months with all-cause hospitalizations: A retrospective cohort study.

Annals of clinical epidemiology
2025

Panniculitis Associated With the Diphtheria-Tetanus-Pertussis Vaccine.

Actas dermo-sifiliograficas
2026

High-pressure injection injury with concrete to the hand and forearm.

Joint diseases and related surgery
2026

Coverage and determinants of maternal RSV vaccination in Japan: A nationwide survey.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2025

Immunity to six vaccine pathogens in HIV positive and HIV negative children in Equatorial Guinea.

Scientific reports
2025

Parental concerns, behaviours, and attitudes associated with childhood vaccinations in Albania: a cross-sectional study.

BMC public health
2026

Pityriasis rubra pilaris triggered by vaccination.

Italian journal of dermatology and venereology
2025

Determinants of quality antenatal care among adolescent girls and women in Sierra leone: insights from the 2019 demographic health survey.

Reproductive health
2025

Decomposition of socioeconomic inequalities in zero-dose children aged 12-23 months in India.

Scientific reports
2026

Accuracy of self-reported vaccination status using surveys in safety-net, integrated and rural health systems in Colorado.

Vaccine
2025

Reporting profile of adverse events following DTaP-IPV/Hib pentavalent vaccine: A 13-year real-world surveillance data analysis.

Human vaccines &amp; immunotherapeutics
2026

Real-world utilization and potential clinical and economic value of recombinant zoster vaccine and select preventive services recommended for older adults in the United States.

Vaccine
2026

Geospatial inequalities in zero-dose vaccination and structural determinants: Insights from sub-Saharan Africa (2015-2023).

Vaccine
2026

Estimating diphtheria, acellular pertussis, tetanus vaccine (DTaP) effectiveness in preventing pertussis in children aged three months to six years old in Shenzhen area, China, case control study.

Vaccine
2025

Social and health system factors associated with maternal mortality in Eastern and Western China: Population health estimates using provincial-level data.

PLoS medicine
2025

Trends in childhood routine immunisation and maternal health service access and utilisation in Sokoto State, Nigeria. A quantitative survey.

Scientific reports
2025

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico.

Human vaccines &amp; immunotherapeutics
2025

Tracking the progress of maternal pertussis vaccination coverage among upper-middle- and high-income countries and territories - a systematic review and modeling study.

EClinicalMedicine
2025

Maternal and child health services during the COVID-19 pandemic in India: an interrupted time-series analysis.

Frontiers in global women's health
2025

Maternal vaccine delivery costs in South Asian settings: estimates from Bangladesh and Nepal.

BMC public health
2025

Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children.

Nature communications
2025

Profile and management of war casualties in the context of limited resources and conflict in the Eastern Democratic Republic of Congo: a retrospective observational study.

BMC public health
2025

Global epidemiology of vaccine-associated intussusception in children and adolescents, 1968 to 2024: An international pharmacovigilance study.

Medicine
2025

Longitudinal Cohort Event Monitoring of MMR and DT-IPV Vaccination at 9 Years of Age in The Netherlands.

Pharmaceuticals (Basel, Switzerland)
2025

Simultaneous Quantification of Multiple Analytes in Rat Plasma by UHPLC-MS/MS Following Oral Administration of Gastrodiae Rhizoma Extract for Pharmacokinetic Evaluation.

Molecules (Basel, Switzerland)
2026

Effectiveness of DTaP-IPV//PRP-T vaccine against pertussis among infants and toddlers in Zhejiang, China: a retrospective cohort study.

Emerging microbes &amp; infections
2026

Biophysical Insights into the Effects of Alkyl Glucoside Surfactant Structural Characteristics on Antigen Stability under Thermal and Mechanical Stress.

ACS biomaterials science &amp; engineering
2026

Comparison of IgG antibody levels, avidity, and subclass distribution against pertussis toxin in children and adolescents after four-dose primary whole-cell (DTwP) or acellular (DTaP) vaccination, each followed by a single DTaP booster.

Immunology letters
2025

Variations in Routine Childhood Vaccination Gaps: A Decomposition Analysis Across 80 Low- and Middle-Income Countries.

Vaccines
2025

[Evaluation of the protective effect of acellular DPT vaccine for booster immunization in 6-year-old children].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2025

[Investigation on awareness of the adjusted DTaP immunization schedule and its influencing factors among immunization service personnel in China in 2025].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2025

Complement-independent pathogenic influences of anti-HMGCR + and anti-SRP + immune-mediated necrotizing myopathy autoantibodies on engineered muscle function.

Skeletal muscle
2025

Vaccination coverage, immune responses, and clinical characteristics in children with PFAPA syndrome: a monocentric prospective study.

Pediatric rheumatology online journal
2026

Effectiveness of 5-pertussis-component tetanus, diphtheria, and acellular pertussis (Tdap5) vaccination in pregnancy at preventing infant pertussis.

American journal of obstetrics and gynecology
2026

Synaptic Silencing with Transactivation of Tetanus Neurotoxin for Pathway-Selective Manipulation.

Methods in molecular biology (Clifton, N.J.)
2026

Optimal neuromuscular performance requires motor neuron phosphagen kinases.

The Journal of physiology
2025

Improving uptake of pediatric vaccines through religious conferences and mobile vaccine clinics in Aceh, Indonesia (TABRIE): study protocol for a stepped wedge cluster randomized controlled trial.

Trials
2025

Utilization of tetanus and diphtheria serology tests in Alberta, Canada: Patterns and implications.

PloS one
2025

Association between vaccinations and risk of dementia: a systematic review and meta-analysis.

Age and ageing
2026

Unveiling the potential of neuron-targeted dendriplexes for siRNA delivery using a PNS-CNS-on-Chip.

Journal of controlled release : official journal of the Controlled Release Society
2026

General Approach to Weakness.

Emergency medicine clinics of North America
2025

Parental vaccine refusal, non-vaccinated children, and outbreaks of Vaccine-Preventable Diseases (VPDs) in Europe: a systematic review of aetiology and risk.

BMC public health
2025

Diphtheria outbreak in Somalia: a weekly sitrep on the recent health crisis-2025.

Tropical medicine and health
2025

Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations.

Frontiers in immunology
Ver todos os 13.441 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tétano.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Tétano

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Caregiver and healthcare professional perspectives on drivers of routine immunisation uptake in East New Britain, Papua New Guinea: a qualitative study.
    BMJ public health· 2026· PMID 41878585mais citado
  2. Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024.
    BMJ public health· 2026· PMID 41878584mais citado
  3. Global patterns and disparities in maternal and child health: a panel analysis of global health observatory and world development indicators data, 2000-2023.
    BMJ open· 2026· PMID 41877334mais citado
  4. Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance.
    BMJ paediatrics open· 2026· PMID 41871912mais citado
  5. Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
    The Lancet. Infectious diseases· 2026· PMID 41865748mais citado
  6. Notes from the Field: Tetanus in Four Children - Idaho, Minnesota, Missouri, and Wisconsin, 2024.
    MMWR Morb Mortal Wkly Rep· 2026· PMID 41989954recente
  7. Hotspot-based integrated serosurveillance of neglected tropical diseases, malaria, and vaccine-preventable diseases in urban Guyana.
    Rev Panam Salud Publica· 2026· PMID 41982851recente
  8. Tetanus Surveillance - United States, 2009-2023.
    MMWR Surveill Summ· 2026· PMID 41980046recente
  9. Long-term trends in childhood mortality following the expansion of vaccination programs: a 60-year analysis from a university hospital in Rio de Janeiro State, Brazil.
    Acta Trop· 2026· PMID 41974316recente
  10. Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis.
    Liver Int· 2026· PMID 41968440recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3299(Orphanet)
  2. MONDO:0005526(MONDO)
  3. GARD:5144(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q47790(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Tétano
Compêndio · Raras BR

Tétano

ORPHA:3299 · MONDO:0005526
Prevalência
Unknown
CID-10
A33 · Tétano do recém-nascido [neonatal]
CID-11
Ensaios
23 ativos
Início
All ages
Prevalência
0.0 (Europe)
MedGen
UMLS
C0039614
Repurposing
1 candidato
chlorpromazinedopamine receptor antagonist
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades